NASDAQ: RKDA
Arcadia Biosciences Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their RKDA stock forecasts and price targets.

Forecast return on equity

Is RKDA forecast to generate an efficient return?

Company
-62.27%
Industry
15.12%
Market
332.43%
RKDA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RKDA forecast to generate an efficient return on assets?

Company
-39.49%
Industry
6.53%
RKDA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RKDA earnings per share forecast

What is RKDA's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$2.61
Avg 2 year Forecast
-$2.47

RKDA revenue forecast

What is RKDA's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$6.1M+18.31%
Avg 2 year Forecast
$7.9M+51.83%
RKDA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RKDA revenue growth forecast

How is RKDA forecast to perform vs Packaged Foods companies and vs the US market?

Company
18.31%
Industry
1.35%
Market
1,465.28%
RKDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RKDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RKDA vs Food Stocks

TickerPricePrice TargetUp/downsideConsensus
RKDA$3.65N/AN/A
ORIS$0.13N/AN/A
PAVS$0.03N/AN/A
SOWG$0.65N/AN/A
FAMI$1.49N/AN/A

Arcadia Biosciences Stock Forecast FAQ

What is RKDA's earnings growth forecast for 2025-2026?

(NASDAQ: RKDA) Arcadia Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Packaged Foods industry's average forecast earnings growth rate of 14.03%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,937.6%.

Arcadia Biosciences's earnings in 2025 is -$5,067,000.On average, 3 Wall Street analysts forecast RKDA's earnings for 2025 to be -$3,585,491, with the lowest RKDA earnings forecast at -$3,444,883, and the highest RKDA earnings forecast at -$3,690,947.

In 2026, RKDA is forecast to generate -$3,389,409 in earnings, with the lowest earnings forecast at -$3,256,491 and the highest earnings forecast at -$3,489,098.

If you're new to stock investing, here's how to buy Arcadia Biosciences stock.

What is RKDA's revenue growth forecast for 2025-2026?

(NASDAQ: RKDA) Arcadia Biosciences's forecast annual revenue growth rate of 18.31% is forecast to beat the US Packaged Foods industry's average forecast revenue growth rate of 1.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,465.28%.

Arcadia Biosciences's revenue in 2025 is $5,173,000.On average, 3 Wall Street analysts forecast RKDA's revenue for 2025 to be $8,403,494, with the lowest RKDA revenue forecast at $8,073,946, and the highest RKDA revenue forecast at $8,650,656.

In 2026, RKDA is forecast to generate $10,784,484 in revenue, with the lowest revenue forecast at $10,361,564 and the highest revenue forecast at $11,101,675.

What is RKDA's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: RKDA) forecast ROA is -39.49%, which is lower than the forecast US Packaged Foods industry average of 6.53%.

What is RKDA's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: RKDA) Arcadia Biosciences's current Earnings Per Share (EPS) is -$3.72. On average, analysts forecast that RKDA's EPS will be -$2.61 for 2025, with the lowest EPS forecast at -$2.51, and the highest EPS forecast at -$2.69. In 2026, RKDA's EPS is forecast to hit -$2.47 (min: -$2.37, max: -$2.54).

What is RKDA's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: RKDA) forecast ROE is -62.27%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.